A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment
Jinho Kang, Yoon Ji Choi, Bo Yeon Seo, Ukhyun Jo, Serk In Park, Yeul Hong Kim, Kyong Hwa Park
Dive into the research topics of 'A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment'. Together they form a unique fingerprint.